You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 12, December 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Effects of Cigarette Smoking on Motor Functions in Patients With Multiple Sclerosis

Murat Emre, MD; Catherine de Decker

Arch Neurol. 1992;49(12):1243-1247.


Abstract

• The acute effects of cigarette smoking on motor functions were examined in 21 patients with multiple sclerosis and 11 healthy control subjects. The motor function in the upper extremities was assessed by a simple test battery. Sixteen of 21 patients had a transient deterioration of their motor function immediately after smoking, lasting for 10 minutes. The mean decrease in motor performance score for all 21 patients was 14%. With the same tests performed without smoking only three of 14 patients had a deterioration and the group had a mean 8% improvement. The control group showed a steady improvement over time, both in smoking and in simulation experiments. We conclude that nicotine causes a transient worsening of motor functions in patients with multiple sclerosis, which can be due to its effects on the central nervous system or vegetative-vascular functions.



Author Affiliations

From the Clinical Research, CNS Department, Sandoz Pharma Ltd, Basel, Switzerland (Dr Emre), and Hôpital de Jour, Hôpital de Gravelone, Sion, Switzerland (Ms de Decker).


Footnotes

Accepted for publication July 20, 1992.

Reprint requests to the Clinical Research, CNS Department, Sandoz Pharma Ltd, 4002 Basel, Switzerland (Dr Emre).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
Shi et al.
J. Immunol. 2009;182:1730-1739.
ABSTRACT | FULL TEXT  

Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Costenbader and Karlson
Lupus 2006;15:737-745.
ABSTRACT  

Environmental risk factors in multiple sclerosis: Causes, triggers, and patient autonomy
Franklin and Nelson
Neurology 2003;61:1032-1034.
FULL TEXT  

Cigarette Smoking and Incidence of Multiple Sclerosis
Hernan et al.
Am J Epidemiol 2001;154:69-74.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.